Liquidia Technologies is trading 5.17% down at $83.49 after adjusted EPS missed expectations despite revenue slightly exceeding forecasts.

  • Adjusted EPS was $0.74 versus $0.76 consensus, while revenue reached $171.68 million against $170.98 million expected.
  • YUTREPIA sales grew strongly, but higher R&D and commercialization expenses pressured results; R&D spending increased 185% year over year.
  • Broader indexes traded higher, indicating a primarily company-specific earnings reaction rather than market weakness; management reaffirmed its long-term $1 billion annual-revenue target for 2027.